Cerebrovascular Disease Clinical Trial
Official title:
Effects of Aerobic Dance Training on Cognitive Functions, Mood and Physical Functions in Community Elderly Persons With Cerebral Small Vessel Disease
Introduction: Cerebral small vessel disease (SVD) is associated with age-related disabilities
including dementia, depression, physical and functional impairment. Chinese are more prone to
developing SVD than Caucasians. Physical exercise may improve multiple negative consequences
associated with SVD.
Objective and hypothesis to be tested: To examine the effects of a 24-week structured aerobic
dance training on cognition, mood, physical and daily functions in stroke and dementia free
older adults with SVD, and whether such effects are mediated through improved cerebral
vasomotor reactivity (CVR), a marker of cerebral autoregulation which is impaired in SVD.
Design and subjects: Rater-blind RCT comparing the effects of 24-week of structured aerobic
dance training upon cognition, mood, physical and daily functions on 110 community dwelling,
stroke- and dementia-free persons aged ≥65 with MRI evidence of significant SVD, defined as
the presence of multiple (≥2) lacunes and/or early confluent or confluent WML.
Interventions: Participants are randomized in a 1:1 ratio into a 24-week of structured
therapist-led group aerobic dance training with home practice or simple stretching plus
health education control group.
Main outcome measures: Cognition, mood, physical and daily functions and CVR measured using
Transcranial Doppler at baseline, weeks 12, 24 and 36.
Data analysis: Intent-to-treat with multiple imputations with treatment efficacy analyzed
using mixed effects models. Mediation effects of CVR between aerobic dance training and
treatment outcomes tested using mediation models.
Expected results: In persons with significant SVD, aerobic dance training improves cognitive,
mood, physical and daily functions and such effects are mediated by changes in CVR.
Cerebral small vessel disease (SVD) is manifested as age-related white matter lesions (WML)
and lacunar infarcts and on brain imaging. SVD is prevalent in the elderly population. In
community dwelling persons ≥ 60 years of age, up to a quarter had lacunar infarcts and 96%
had varying degree of WML. Significant SVD, namely early confluent or confluent WML and
multiple lacunar infarcts, are found in up to 1 in every 5 elderly persons. In a previous
study we found that Chinese are more prone to develop significant SVD than Caucasians. SVD is
associated with a plethora of age-related disabilities such as dementia, falls, depression,
impaired daily functioning and death Cognition - SVD is the most common cause of vascular
cognitive impairment (VCI) and vascular dementia, which is the second most prevalent type of
dementia. Community elderly persons with SVD had two-fold increased risk of developing
dementia when compared to those without. SVD may direct damage neural structures, disrupt
connectivity or cause atrophy in brain regions important for cognitive functioning.
Depression - Disconnection of frontosubcortical pathways by SVD contributes to late-life
depression, and increased comorbidity of depression and SVD has been observed in the older
populations. Depression contributes to poor quality of life and death in older persons.
Physical impairment - increased severity of SVD is associated with poor physical functions
including poor gait and balance. SVD is a strong risk factor for falls, a major contributing
factor for disability and death in older persons. In summary, non-disabled older adults with
SVD are at high risk of multiple disabilities.
As the elderly population in Hong Kong is projected to triple over the next 30 years, means
to prevent age-related disabilities such as cognitive decline, depression and physical
impairments in vulnerable individuals are of enormous importance to the patient, family and
healthcare system. Existing preventive therapies mainly involve medications to control
vascular risk factors associated with SVD. Primary prevention by means of lifestyle
intervention is therefore of utmost importance.
Evidence on effects of physical activities upon cognition, mood and physical functions The
health values of physical activities are well recognized. Physical activities can be
performed by anybody at any time and place at minimal cost. Physical activities are shown to
improve the clinical conditions associated with SVD. For cognition, physical activities are
associated with reduced risk of cognitive decline in normal and cognitively impaired elderly
persons. Aerobic and strength training improved executive functions, memory and general
cognitive functions in community-dwelling adults with mild cognitive impairment. The
investigators showed that in a large cohort (n=1,013) of stroke patients free of dementia
before the stroke, participation in regular physical activities reduced 79% of risk of
incident dementia after stroke. With regard to the mechanism, physical activities may improve
endothelial functions and blood perfusion and neuroplasticity in brain regions mediating
cognitive functions. Moreover, physical exercise may protect cognition by reducing incident
strokes, which is particular relevant to people with SVD due to their increased risk of
strokes. A randomized controlled trial (RCT) showed that a 24-week, 3 x 50-minute per week of
moderate intensity exercise intervention significantly improved cognitive functions in
patients at risk of AD, with outcome effect size superior to that reported for drug treatment
in another study. Moreover, treatment benefits persisted at least one year after active
intervention, suggesting that physical exercise is associated with enduring changes in the
neurological substrate underpinning cognitive functioning. However, this study only recruited
patients likely to have degenerative (Alzheimer's) pathology. For mood, physical activities
may protect against depression in older adults. For physical functions, the investigators
previously showed that physical exercise training improved balance, gait performance,
exercise endurance and quality of life in local patients with Parkinson's Disease (PD). Taken
together, there is good evidence that physical activities can improve many of the negative
consequences of cerebral SVD.
Possible biological mechanism underlying physical exercise in SVD The development of SVD is
hypothesized to be related to endothelial dysfunction that results from chronic hypertension
impairs cerebral vasomotor reactivity (CVR), a marker of cerebral autoregulation. Changes in
CVR may reflect impairment in the homeostasis of blood pressure in the brain, hence cerebral
perfusion becomes more dependent on the systemic blood pressure. Ischemia occurs in response
to drop of systemic blood pressure and lead to hypoperfusion and subsequently the development
of SVD. Using Transcranial Doppler (TCD) ultrasonography, our group previously showed that
decreased CVR is associated with SVD. Reduced CVR is linked to cognitive decline, depression
and poor physical functions in elderly persons. Physical exercise may lead to significant
improvement in CVR. These data suggest that physical exercise is likely to benefit cognition,
mood and physical functions in persons with SVD due to its positive effects on CVR.
Dancing as a mean of physical activity intervention Dance is a rhythmic movement usually
performed with music. To many, it is a pleasurable activity that can be taken up as a hobby
and social activity and therefore engagement can be self-sustaining. It is of minimal-cost
and can be performed even in older persons with physical and cognitive impairment. Dancing
involves movement of the body and limbs and is in itself a physical training. It also
involves memory, attention, sensory stimulation, social interaction, emotional perception and
expression that presumably could protect against cognitive decline and depression. Dance
training may improve verbal fluency, word list delayed recall and word list recognition in
older adults with metabolic syndrome, suggesting that dance may be effective in preventing
cognitive decline. Aerobic dance also has been shown to enhance exercise endurance strength,
balance, agility and gait performance in older adults. Our team had previously designed and
implemented a balance dance to a group of patients with PD for 8 weeks. Together with other
training, balance ability and walking speed increased and the effects lasted for 12 months
after treatment completion. Given the likely positive effects of aerobic dance, it appears to
be a good exercise candidate for enhancing cognitive, mood and physical functions in patients
with cerebral SVD.
Data Collection Assessment of cognitive functions The 30-minute protocol of the National
Institute of Neurological Diseases and Stroke - Canadian Stroke Network VCI protocols will be
used. The 30-minute protocol provides a comprehensive assessment of cognitive functions with
emphasis on executive functions, psychomotor speed and memory, which are the cognitive
domains predominately impaired in VCI. With support from Health and Health Service Research
fund (PI: Vincent CT MOK; Reference Number 06070231), the investigators adapted and validated
the 30-minute protocol in a group of Chinese stroke patients and controls and demonstrated
good external validity (area under ROC=0.79 [95%CI 0.69-0.89], p<0.001) in differentiating
stroke patients from non-stroke controls and concurrent validity with functional measures. In
addition to the 30-minute protocol, the digit span tests from the Wechsler Memory Scale will
be administered because of the involvement of immediate attention and working memory in VCI.
Measure of depressive symptoms The 15-item Geriatric Depression Scale (GDS), which is a
self-reported questionnaire to rate depressive symptoms in elderly persons, will be used. It
has been used in local study on SVD patients and demonstrated excellent classification power
>90% in detecting depression in the local elderly population.
Measures of physical functions The Mini-Balance Evaluation Systems Test (Mini-BESTest) will
be used to assess dynamic balance performance of individuals. The 14-item Mini-BESTest
represents 4 dynamic balance domains: anticipatory postural adjustments, postural responses,
sensory orientation and stability in gait. Each item is rated from 0 to 2, and the total
score ranges from 0-28 with a higher score indicating better balance.
The Timed-up-and-go test (TUG) will be used to examine functional mobility of subjects. This
test measures the time which participants takes to rise from the chair, walk 3 meters, turn
around, walk back to the chair and sit down.
The 6-minute walk test will be used to determine the walking capacity. This test measures the
distance (in metres) participants walk in 6 minutes. Participants will walk at their own
speed, and stops and resting are allowed if necessary.
Measure of daily functions The Lawton's Instrumental Activities of Daily Living (IADL) will
be used to assess complex activities of daily functions that are impaired early in patients
with SVD. It take about 10 minutes to administer and contains 8 items including ability to
use telephone, shopping, food preparation, housekeeping, laundry, taking transportation,
handling medications and finances. It is has been used as a primary outcome instrument in the
Pan-European Leukoaraiosis and Disability in the Elderly Study in SVD.
Measure of overall physical activities Physical activities performed outside of training
session will be recorded using the long form of the International Physical Activity
Questionnaire (IPAQ). The IPAQ has been very widely used in studies of physical activity
across different ages and medical conditions (http://www.ipaq.ki.se/publications.htm). The
IPAQ records the types, frequency and duration of physical activities across 4 activity
domains including leisure time physical activity, domestic related physical activities,
work-related and transportation related physical activities. The IPAQ yields scores for
walking, moderate-intensity and vigorous-intensity activities with each of these activity
domains. A total score is calculated by summing the duration and frequency for all types of
activities across all domains. This score will be used to account for the potential
confounding effects of physical activities performed outside of training session in both
groups.
It is estimated that it takes approximately 2 hours to complete the assessment and TCD
examination. To avoid rater bias, the research assistant (RA) who performs the study
assessment will be blind to treatment allocation and encouraged not to discuss with the
participants about the interventions. Clinical assessments will be performed by a trained RA
under the supervision of a qualified clinical psychologist (PI of this application).
TCD Examination TCD examination will be performed at baseline, weeks 12, 24 and 36. A 2-MHz
pulsed Doppler hand-held probe is used to insonate the middle cerebral artery (MCA) through
temporal window above the zygomatic arch at a depth of 52-56mm, and the vertebral artery (VA)
through occipital window at a depth of 64mm. The Pulsatility Index (PI) and Breath Holding
Index (BHI) will be calculated. The PI is a measure of vascular resistance of cerebral
vessels. The mean PI of the middle MCA and vertebral VA will be obtained. A previous study by
the investigators showed that these measures highly differentiated stroke patients with and
without WML on MRI (AUC = 0.85 [MCA] and 0.81 [VA], sensitivity and specificity between 70
and 82%]). According to the standard protocol, the simple breath holding procedure will be
performed during the same TCD session to obtain the BHI, which will serve as a marker of CVR.
A trained postgraduate research student under the supervision of a broad certified
neurologist (Co-A Vincent MOK) will perform the TCD blind to participant's treatment
allocation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02248311 -
"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population
|
N/A | |
Completed |
NCT01604486 -
Natural Ischaemic Preconditioning Before First Myocardial Infarction
|
N/A | |
Active, not recruiting |
NCT00627029 -
Evaluation of Programs of Coordinated Care and Disease Management
|
N/A | |
Recruiting |
NCT04336852 -
Development of a Clinically-relevant Test for Assessment of Cerebral Vascular Function
|
N/A | |
Not yet recruiting |
NCT06429332 -
International Care Bundle Evaluation in Cerebral Hemorrhage Research
|
Phase 4 | |
Not yet recruiting |
NCT05925699 -
National Database of the Virtual Institute of Cerebrovascular Diseases
|
||
Recruiting |
NCT04443439 -
Assess the Risk of Cerebrovascular Disease
|
||
Recruiting |
NCT04525144 -
EGb 761 in the Syndrome of MCI With Concomitant CVD
|
Phase 2 | |
Completed |
NCT02553655 -
Remote Ischemic Limb Preconditioning In Healthy Volunteers
|
N/A | |
Recruiting |
NCT00385385 -
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
|
Phase 2 | |
Recruiting |
NCT05247931 -
Why Does Aspirin Fail in Secondary Cerebrovascular Prevention? A Multicenter Prospective Case - Control Study
|
||
Completed |
NCT02665585 -
Plaque Prolapse Prevention Carotid Artery Stenting (3PCAS)
|
N/A | |
Recruiting |
NCT05834673 -
VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)
|
Phase 4 | |
Recruiting |
NCT06115213 -
The North Kynouria Project
|
N/A | |
Terminated |
NCT02440646 -
Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomography Angiography in Comparison With Invasive Multimodality Imaging
|
||
Completed |
NCT01924312 -
Early Detection and Prevention of Mild Cognitive Impairment Due to Cerebrovascular Disease
|
N/A | |
Completed |
NCT00333164 -
Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis
|
Phase 3 | |
Not yet recruiting |
NCT06241482 -
Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care
|
N/A | |
Enrolling by invitation |
NCT02694094 -
Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy
|
||
Not yet recruiting |
NCT04696120 -
Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial
|
Phase 2 |